Industry reports
Editor highlights

Publication dates

Publishers

All regions

Pharmaceutical Research Reports, April 2014

You might be interested in: therapeutics, medical equipment, cancer, more »


 

1-20 of about 23 000 reports for Pharmaceutical
Starch Derivatives Market by Type (Maltodextrin, Cyclodextrin, Glucose Syrup, Hydrolysates And, Modified Starch) & by Application (Food & Beverage, Feed, Paper, Cosmetics, Pharmaceutical, Bioethanol) - Global Trends & Forecast To 2019

Starch Derivatives Market by Type (Maltodextrin, Cyclodextrin, Glucose Syrup, Hydrolysates And, Modified Starch) & by Application (Food & Beverage, Feed, Paper, Cosmetics, Pharmaceutical, Bioethanol) - Global Trends & Forecast To 2019

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

... They are used as a thickener, stabilizer, etc., As a tablet binder in the pharmaceutical sector, as an emulsifier in cosmetics, fiber additive in the animal feed, etc. The other functions of starch derivatives ...

Aegerion Pharmaceuticals Incorporation

Aegerion Pharmaceuticals Incorporation

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Aegerion pharmaceuticals incorporation a textual analysis of the financial results for aegerion pharmaceuticals incorporation compared to selected competitors. Also included are quantitative ...

Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp.

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Equity). Also included for raptor pharmaceutical corp. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub ...

Jintian Pharmaceutical Group Ltd

Jintian Pharmaceutical Group Ltd

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Jintian pharmaceutical group ltd a textual analysis of the financial results for jintian pharmaceutical group ltd compared to selected competitors. Also included are quantitative analyses ...

Neurovive Pharmaceutical AB

Neurovive Pharmaceutical AB

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... pharmaceutical ab are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal year end month, employees ...

Middle East Pharmaceutical & Chemical In

Middle East Pharmaceutical & Chemical In

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Sales and 52-week price change) and financial position (long-term debt/equity). Also included for middle east pharmaceutical & chemical in are the company description, recent stock performance, profitability ...

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Greece Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

... No lessening in the pressures on the greek pharmaceutical and healthcare sectors over the medium- to long term. Further discussions with country's troika of lenders clearly indicate that more cuts to spending ...

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • April 2014
  • by Business Monitor International

... Surrounding intellectual property protection, in which the innovative pharmaceutical association sa (ipasa) was implicated in the leakage of draft response campaigning against proposed changes to south africa ...

Welcure Drugs & Pharmaceuticals Limited

Welcure Drugs & Pharmaceuticals Limited

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Welcure drugs & pharmaceuticals limited a textual analysis of the financial results for welcure drugs & pharmaceuticals limited compared to selected competitors. Also included are quantitative ...

CFR Pharmaceuticals S.A.

CFR Pharmaceuticals S.A.

  • $ 55
  • Company report
  • April 2014
  • by Wright Investors' Service

... Included for cfr pharmaceuticals s.A. Are the company description, recent stock performance, profitability analysis, dividend analysis, and key data items (ticker, major industry, sub-industry, fiscal year ...


» Read our Company Profiles

64 Companies for Pharmaceutical

GlaxoSmithKline P.L.C.

United States

Icon Group

United States

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.